Institutional investors purchased a net $3.4 million shares of DTIL during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 50.48% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 1.8 Million shares of Precision BioSciences Inc
CITADEL ADVISORS LLC Bought 1.4 Million shares of Precision BioSciences Inc